KANGO SUJAY
Insider CIK 1336503 · INFI Chief Commercial Officer, Director · MEIP Director · XLRN SVP, Chief Commercial Officer · DNTH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2026-05-21 | 2026-05-22 | 6,090 | — | $0 | 6,090 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2025-03-04 | 2025-03-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2023-09-29 | 2023-10-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2022-07-05 | 2022-07-07 | 87,500 | — | $0 | 87,500 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2022-03-30 | 2022-03-31 | 90,000 | — | $0 | 90,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2021-11-22 | 2021-11-23 | 58,334 | — | $0 | 58,334 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 25,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 25,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 24,334 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 20,896 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | U Tender | 2021-11-19 | 2021-11-22 | 18,509 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-09-27 | 2021-09-27 | 5,000 | — | $0 | 25,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-09-27 | 2021-09-27 | 5,000 | $175.00 | $875.0K | 18,509 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-09-27 | 2021-09-27 | 5,000 | $40.61 | $203.1K | 23,509 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-09-21 | 2021-09-22 | 5,000 | — | $0 | 30,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-09-21 | 2021-09-22 | 5,000 | $150.03 | $750.1K | 18,509 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-09-21 | 2021-09-22 | 5,000 | $40.61 | $203.1K | 23,509 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-03-02 | 2021-03-04 | 5,000 | — | $0 | 35,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-03-02 | 2021-03-04 | 600 | $137.12 | $82.3K | 19,596 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-03-02 | 2021-03-04 | 200 | $138.15 | $27.6K | 19,396 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-03-02 | 2021-03-04 | 1,501 | $136.24 | $204.5K | 20,196 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-03-02 | 2021-03-04 | 5,000 | $40.61 | $203.1K | 24,396 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-03-02 | 2021-03-04 | 2,699 | $135.48 | $365.7K | 21,697 | SEC↗ |
| XLRN ACCELERON PHARMA INC | F Tax w/h | 2021-02-12 | 2021-06-08 | 887 | $130.87 | $116.1K | 18,509 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2021-01-29 | 2021-02-02 | 20,896 | — | $0 | 20,896 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2021-01-29 | 2021-02-02 | 5,409 | — | $0 | 19,396 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-01-04 | 2021-02-02 | 10,000 | — | $0 | 40,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-04 | 2021-01-06 | 3,429 | $125.17 | $429.2K | 8,611 | SEC↗ |
| XLRN ACCELERON PHARMA INC | F Tax w/h | 2021-01-04 | 2021-01-06 | 1,357 | $124.31 | $168.7K | 13,987 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-04 | 2021-01-06 | 1,947 | $123.90 | $241.2K | 12,040 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-04 | 2021-01-06 | 4,624 | $126.15 | $583.3K | 3,987 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-01-04 | 2021-02-02 | 10,000 | $40.61 | $406.1K | 13,987 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-02-13 | 2020-02-14 | 590 | $94.09 | $55.5K | 15,349 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-02-13 | 2020-02-14 | 5 | $94.82 | $474 | 15,344 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-22 | 2020-01-24 | 24,334 | — | $0 | 24,334 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2020-01-22 | 2020-01-24 | 6,369 | — | $0 | 15,939 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-01-03 | 2020-01-03 | 469 | $51.37 | $24.1K | 9,581 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-01-03 | 2020-01-03 | 11 | $51.27 | $564 | 9,570 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2019-01-25 | 2019-01-29 | 25,500 | — | $0 | 25,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2019-01-25 | 2019-01-29 | 4,050 | — | $0 | 10,050 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-03-01 | 2018-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-02-12 | 2018-02-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2016-12-13 | 2016-12-14 | 7,676 | $1.25 | $9.6K | 599 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2016-12-13 | 2016-12-14 | 298 | $1.30 | $387 | 50,292 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2016-12-13 | 2016-12-14 | 42,017 | $1.27 | $53.4K | 8,275 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2016-12-12 | 2016-12-14 | 25,009 | $1.30 | $32.5K | 50,590 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2016-10-31 | 2016-11-02 | 75,000 | — | $0 | 75,599 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2016-01-06 | 2016-01-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2015-03-31 | 2015-04-01 | 200,000 | — | $0 | 200,000 | SEC↗ |